Paracetamol Plus Tramadol Versus Fentanyl in Day Case Surgeries
Preemptive Intravenous Paracetamol Plus Tramadol Versus Preemptive Intravenous Fentanyl in Day Case Surgeries
1 other identifier
observational
132
1 country
1
Brief Summary
Postoperative pain is an important problem, especially for day case surgeries. It has negative effects on patient's hemodynamics and can cause delayed ambulation resulting in prolonged duration of hospital stay and poor patient satisfaction. Multiple analgesic strategies have been proposed including NSAID, opioids, epidural analgesia. Each of them has its limitations. In this study the investigators will compare between the effect of preemptive use of paracetamol plus tramadol versus preemptive intravenous fentanyl in controlling postoperative pain
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Jan 2023
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 10, 2023
CompletedFirst Submitted
Initial submission to the registry
July 29, 2023
CompletedFirst Posted
Study publicly available on registry
August 14, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 30, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
September 30, 2024
CompletedFebruary 28, 2024
February 1, 2024
1.6 years
July 29, 2023
February 27, 2024
Conditions
Outcome Measures
Primary Outcomes (1)
postoperative analgesia
Assess quality of postoperative analgesia in both groups analogue score (VAS) scale where zero means no pain and ten means worst pain
immediately postoperative (0 hour), 1 hour, 2 hours , 4 hours, 6 hours and 12 hours
Secondary Outcomes (5)
mean arterial Blood pressure
5 minutes after start of surgery (intraoperative) , immediately after surgery (0 hour) , 1 hour, 2 hours , 4 hours , 6 hours and 12 hours after surgery
rescue analgesic
immediately after surgery (0 hour) , 1 hour, 2 hours , 4 hours , 6 hours and 12 hours after surgery
side effects
up to twenty four hours after surgery
length of hospital stay
up to twenty four hours after surgery
Heart Rate
5 minutes after start of surgery ( intraoperative), immediately after surgery (0 hour) , 1 hour, 2 hours , 4 hours , 6 hours and 12 hours after surgery
Study Arms (2)
paracetamol plus tramadol
randomized selection of 66 adult patients
fentanyl
randomized selection of 66 adult patients
Interventions
After routine pre-operative evaluation, standard monitors will be connected to the patients: pulse oximetery, noninvasive blood pressure and electrocardiogram and baseline parameter will be recorded (heart rate, mean arterial pressure and peripheral oxygen saturation). Intravenous (IV) line will be inserted for all patients, and IV fluid will be started. Intravenous infusion of 15mg/kg paracetamol together with 1mg/kg tramadol will be started and to be finished before starting of induction of anaesthesia (induction agent will be Propofol 2mg/kg)
After routine pre-operative evaluation, standard monitors will be connected to the patients: pulse oximetery, noninvasive blood pressure and electrocardiogram and baseline parameter will be recorded (heart rate, mean arterial pressure and peripheral oxygen saturation). Intravenous (IV) line will be inserted for all patients, and IV fluid will be started...Intravenous injection of 1microgram/kg fentanyl will be given to the patient followed by induction agents ( propofol 2mg/kg). .
Eligibility Criteria
patients scheduled for a day case surgeries
You may qualify if:
- Patients scheduled for day case surgeries.
- Both sex
- Patient's age 21 - 60 years.
- Patients with ASA physical status I, II.
- BMI 25 - 30 kg m-2.
You may not qualify if:
- Uncooperative patients and patients with psychological problems.
- Patients with liver or renal impairment..
- Patients with history of allergy to drug used in the study.
- Patients with chronic pain.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Zagazig University , Fuculty of Medicine
Zagazig, Sharquia, 7120730, Egypt
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
MICHAEL A shaker, lecturer
Zagazig University
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER GOV
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- lecturer of anesthesia and intensive care
Study Record Dates
First Submitted
July 29, 2023
First Posted
August 14, 2023
Study Start
January 10, 2023
Primary Completion
August 30, 2024
Study Completion
September 30, 2024
Last Updated
February 28, 2024
Record last verified: 2024-02